| 产品详情 |
| Edit |   |
|---|
| Product Name | Altiratinib |
|---|
| Description | MW: 510.46. Purity ≥98% by HPLC. Altiratinib is a selective and highly potent inhibitor of MET; TIE2; VEGFR2 and TRK kinases with potential anticancer activity. It effectively reduces tumor burden in vivo and blocks c-MET pTyr (1349)-mediated signaling; cell growth and migration as compared with a HGF antagonist in vitro. Through its balanced inhibitory potency versus MET; TIE2; and VEGFR2; altiratinib inhibits three major evasive (re) vascularization and resistance pathways (HGF; ANG; and VE |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [N- (4- ( (2- (cyclopropanecarboxamido) pyridin-4-yl) oxy)-2; 5-difluorophenyl)-N- (4-fluorophenyl) cyclopropane-1; 1-dicarboxamide; DCC-2701] |
|---|
| Gene, Accession, CAS # | CAS: 1345847-93-9 |
|---|
| Catalog # | MBS845743 |
|---|
| Price | |
|---|
| Order / More Info | Altiratinib from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|